Andrew Matthius 
The Evolution of Biosimilars from Their Beginning Until Now—And What’s Next
Chrys Kokino has been involved in the biosimilars market prior to the first biosimilar ...
Delivering Improved Disease Awareness Through More Strategic Partnerships
Can an art installation teach you about a disease? How about a song? Or ...
Taking the Necessary Steps to Enhance the Patient Experience
As life sciences companies continue to preach patient centricity or a patient-first approach, it ...
What’s New in the World of Laptops?
For the most part, the biggest changes laptop manufacturers make each year to their ...
My Other Life with Patrick L. Sutton
PM360 recently spoke to Patrick L. Sutton, Vice President, Patient & Specialty Services, Cardiovascular, ...
Table Test Post
Over-the-Counter (OTC) and Prescription (Rx) brands have invested over $3 billion in linear TV ...
PM360 Q&A with Adrian Adams, Chairman & CEO, Impel Pharmaceuticals
Over the course of his career, Adrian Adams has served as CEO of seven ...
Readjusting the Life Sciences Industry’s Approach to Improving Adherence
Addressing the issue of medication adherence begins before a patient even fills their first ...
Tech for the Great Outdoors
Summer isn’t over yet, which probably means you would like to spend less time ...
My Other Life with Craig Mattes
PM360 recently spoke to Craig Mattes, General Manager at Fingerpaint, about the mental and ...
FINN Partners Further Expands into Asia with Addition of SPAG
FINN Partners, an independent marketing and communications agency, is expanding its global footprint even ...
Ashfield and Huntsworth Unite to Form Inizio
Ashfield and Huntsworth continue their transformation since both organizations were acquired by private equity ...
The Creative Floor Awards Announce the 2022 Finalists
The Creative Floor Healthcare Awards has announced this year’s finalists. Entries have come from ...